Unique Neisseria Meningitidis B Capsular Epitopes
Unique Neisseria Meningitidis B Capsular Epitopes
批准号:
7418986
负责人:
GREGORY R MOE
金额:
$60.29万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-15 至 2010-04-30
关键词:
AcidsAddressAminesAnabolismAntibodiesAntigenic SpecificityAntigensAutoantibodiesBacteremiaBacteriaBindingCaviaChemicalsComplementConjugate VaccinesDepositionDevelopmentDiseaseEncapsulatedEnzyme-Linked Immunosorbent AssayEpitopesFlow CytometryGoalsGroup StructureHumanHuman Cell LineImmune SeraImmunizationInfantInvestigationLifeManufacturer NameMass Spectrum AnalysisMeasuresMediatingMethodsMicrobiologyModelingMonoclonal AntibodiesMusNMR SpectroscopyNeisseria meningitidisNeuraminic AcidsOrganic solvent productOrganismPathogenesisPolymersPolysaccharidesPolysialic AcidPreventionProteinsRattusRiskRoleSafetySerumSialic AcidsStructureSurfaceTestingTissuesTo autoantigenTodayVaccinesbactericidebasecapsulechemical synthesisdesigndisorder preventionimmunogenicitymeningococcal group B polysaccharidemicrocalorimetrymutantnovelnovel strategiespathogenprototype
中文摘要
描述(由申请人提供):脑膜炎奈瑟菌B群荚膜多糖(MBPS)是α (2-8) n -乙酰神经氨酸的聚合物,化学上与自身抗原聚唾液酸(PSA)相同。用丙酰取代n -乙酰基(N-Pr - MBPS)的MBPS蛋白结合疫苗免疫小鼠,可产生一种具有杀菌作用但不与人PSA交叉反应的血清抗体亚群。我们已经鉴定出在合成N-Pr MBPS过程中产生的去n -乙酰化MBPS衍生物,这些衍生物也存在于B群细菌的胶囊中,并且是抗N-Pr MBPS抗菌单克隆抗体(mAb)的靶标,该抗体不与人PSA抗原交叉反应。本提案的目标是:1)开发新的化学和生物合成方法来制备去n-乙酰基MBPS衍生物,用于确定其他非自反应性抗菌抗囊单抗识别的表位结构,并用于制备MBPS原型疫苗。我们的假设是,由同一疫苗引发的其他保护性、非自身反应性单克隆抗体也能识别含有去n-乙酰基残基的MBPS衍生物,并且NmB细菌自然表达相同或类似的MBPS表位。2)确定B族细菌自然表达的荚膜PS表位的结构,这些表位可以被非自反应性杀菌单抗识别。我们的假设是,非自反应性抗包膜单抗识别的B族包膜表位与N-Pr MBPS化学合成过程中产生的MBPS衍生物相似或模仿,并且很少存在于宿主组织中。3)基于MBPS衍生物和B族胶囊中独特的荚膜表位,开发B族疫苗。我们的假设是,确定的表位可以用来设计抗原,引发杀菌,非自身反应性抗体。因此,该建议提供了一种新的方法来开发保护性的基于ps的疫苗,避免了引发自身抗体的安全问题,并了解B组荚膜和宿主PSA抗原之间的结构差异。
英文摘要
DESCRIPTION (provided by applicant): The Neisseria meningitidis group B capsular polysaccharide (MBPS) is a polymer of alpha(2-8) N-acetyl neuraminic acid and is chemically identical to an autoantigen, polysialic acid (PSA). Immunization of mice with a MBPS-protein conjugate vaccine in which N-acetyl groups have been replaced by propionyl groups (N-Pr MBPS) elicits a subpopulation of serum antibodies that are bactericidal but do not cross-react with human PSA. We have identified de-N-acetylated derivatives of MBPS that are produced during the synthesis of N-Pr MBPS that are also in the capsule of group B bacteria and are the target of a bactericidal anti-N-Pr MBPS monoclonal antibody (mAb) that does not cross-react with human PSA antigens. The goals of this proposal are: 1) Develop novel chemical and biosynthetic methods for preparing de-N-acetyl MBPS derivatives for use in determining the structure of epitopes recognized by other non-auto-reactive bactericidal anticapsular mAbs and for preparing prototype MBPS vaccines. Our hypothesis is that other protective, non- autoreactive mAbs elicited by the same vaccine also recognize MBPS derivatives containing de-N-acetyl residues and that NmB bacteria naturally express the same or similar MBPS epitopes. 2) Determine the structure of capsular PS epitopes expressed naturally by group B bacteria that are recognized by non- autoreactive, bactericidal mAbs. Our hypothesis is that group B capsular epitopes recognized by non- autoreactive anticapsular mAbs are similar to or are mimicked by MBPS derivatives produced during the chemical synthesis of N-Pr MBPS and are present rarely, if at all in host tissues. 3) Develop a group B vaccine based on the unique capsular epitopes identified in MBPS derivatives and the group B capsule. Our hypothesis is that the epitopes identified can be used to design antigens that elicit bactericidal, non- autoreactive antibodies. Thus, this proposal offers a novel approach to develop a protective PS-based vaccine that avoids safety concerns of eliciting autoantibodies and for understanding structural differences between group B capsular and host PSA antigens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neisseria meningitidis Ig binding protein vaccine
-
批准号:8068251
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2010
-
负责人:GREGORY R MOE
-
依托单位:
Neisseria meningitidis Ig binding protein vaccine
-
批准号:7975755
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2010
-
负责人:GREGORY R MOE
-
依托单位:
Unique Neisseria Meningitidis B Capsular Epitopes
-
批准号:7228906
-
项目类别:
-
资助金额:$59.66万
-
财政年份:2006
-
负责人:GREGORY R MOE
-
依托单位:
Unique Neisseria Meningitidis B Capsular Epitopes
-
批准号:7615582
-
项目类别:
-
资助金额:$67.99万
-
财政年份:2006
-
负责人:GREGORY R MOE
-
依托单位:
Unique Neisseria Meningitidis B Capsular Epitopes
-
批准号:7098144
-
项目类别:
-
资助金额:$57.5万
-
财政年份:2006
-
负责人:GREGORY R MOE
-
依托单位:
Unique Neisseria Meningitidis B Capsular Epitopes
-
批准号:7057936
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2005
-
负责人:GREGORY R MOE
-
依托单位:
MIMETICS OF CAPSULAR EPITOPES OF NEISSERIA MENINGITIDIS
-
批准号:6706889
-
项目类别:
-
资助金额:$62.08万
-
财政年份:2000
-
负责人:GREGORY R MOE
-
依托单位:
MIMETICS OF CAPSULAR EPITOPES OF NEISSERIA MENINGITIDIS
-
批准号:6511018
-
项目类别:
-
资助金额:$58.51万
-
财政年份:2000
-
负责人:GREGORY R MOE
-
依托单位:
MIMETICS OF CAPSULAR EPITOPES OF NEISSERIA MENINGITIDIS
-
批准号:6632107
-
项目类别:
-
资助金额:$60.27万
-
财政年份:2000
-
负责人:GREGORY R MOE
-
依托单位:
TRANSMEMBRANE SIGNALING BY RECEPTOR PROTEINS
-
批准号:3893928
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:GREGORY R MOE
-
依托单位:
海外基金